Evan Kearns - 25 Jan 2022 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Legal Officer
Signature
/s/ Ryan Murr, Attorney-in-Fact
Issuer symbol
COGT
Transactions as of
25 Jan 2022
Transactions value $
$999,762
Form type
4
Filing time
27 Jan 2022, 16:42:26 UTC
Next filing
15 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $999,762 +202,250 $4.94 202,250 25 Jan 2022 Common Stock 202,250 $7.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in equal monthly installments over a four year period.